1. Home
  2. TOPP vs IPA Comparison

TOPP vs IPA Comparison

Compare TOPP & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • IPA
  • Stock Information
  • Founded
  • TOPP 2014
  • IPA 1983
  • Country
  • TOPP United States
  • IPA United States
  • Employees
  • TOPP N/A
  • IPA N/A
  • Industry
  • TOPP
  • IPA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOPP
  • IPA Health Care
  • Exchange
  • TOPP NYSE
  • IPA Nasdaq
  • Market Cap
  • TOPP 23.1M
  • IPA 20.6M
  • IPO Year
  • TOPP 2025
  • IPA 2017
  • Fundamental
  • Price
  • TOPP $1.72
  • IPA $0.50
  • Analyst Decision
  • TOPP
  • IPA Strong Buy
  • Analyst Count
  • TOPP 0
  • IPA 2
  • Target Price
  • TOPP N/A
  • IPA $4.00
  • AVG Volume (30 Days)
  • TOPP 155.3K
  • IPA 341.2K
  • Earning Date
  • TOPP 01-01-0001
  • IPA 03-28-2025
  • Dividend Yield
  • TOPP N/A
  • IPA N/A
  • EPS Growth
  • TOPP N/A
  • IPA N/A
  • EPS
  • TOPP 0.01
  • IPA N/A
  • Revenue
  • TOPP $16,039,513.00
  • IPA $16,581,105.00
  • Revenue This Year
  • TOPP N/A
  • IPA $4.67
  • Revenue Next Year
  • TOPP N/A
  • IPA $14.15
  • P/E Ratio
  • TOPP $144.11
  • IPA N/A
  • Revenue Growth
  • TOPP N/A
  • IPA 1.34
  • 52 Week Low
  • TOPP $0.97
  • IPA $0.27
  • 52 Week High
  • TOPP $4.50
  • IPA $1.36
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • IPA 61.95
  • Support Level
  • TOPP N/A
  • IPA $0.44
  • Resistance Level
  • TOPP N/A
  • IPA $0.48
  • Average True Range (ATR)
  • TOPP 0.00
  • IPA 0.03
  • MACD
  • TOPP 0.00
  • IPA 0.00
  • Stochastic Oscillator
  • TOPP 0.00
  • IPA 85.21

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.

About IPA ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

Share on Social Networks: